Cargando…
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly approved antibiotics for clinical usage, we are on the verge of not having effective treatments for many common infectious diseases. Historically, antibiotic discovery has been crucial in outpacing resist...
Autores principales: | Ribeiro da Cunha, Bernardo, Fonseca, Luís P., Calado, Cecília R. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627412/ https://www.ncbi.nlm.nih.gov/pubmed/31022923 http://dx.doi.org/10.3390/antibiotics8020045 |
Ejemplares similares
-
Managing sarcoma: where have we come from and where are we going?
por: Bleloch, Jenna S., et al.
Publicado: (2017) -
Nanoparticles in the environment: where do we come from, where do we go to?
por: Bundschuh, Mirco, et al.
Publicado: (2018) -
Introduction to sessions on 'Endocrine therapy: where have we come from, where are we at and where are we going to?'
por: Ingle, James N
Publicado: (2008) -
Where are we coming from? What are we? Where are we going?
por: Ellis, John R.
Publicado: (1995) -
Dermatology: Where are We Coming from and Where are We Going to?
por: van de Kerkhof, Peter C. M.
Publicado: (2014)